NPC
CPXX

National Planning Corporation’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

National Planning Corporation’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,000
Closed -$2.14K – 2547
2014
Q4 		$2.14K Buy
+1,000
New +$2.07K ﹤0.01% 2572

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Planning Corporation's CPXX Position: Q1 2015 in Review

National Planning Corporation sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q1 2015, closing a stake of 1,000 shares — an estimated $2.14K sold.

National Planning Corporation first reported a position in CPXX in Q4 2014 and held it in 1 quarter. The position peaked at $2.14K in Q4 2014. 15 funds tracked by Wall St. Rank hold CPXX as of Q1 2015.

  • National Planning Corporation reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 1,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q1 2015, an estimated $2.14K.
  • National Planning Corporation first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $2.14K in Q4 2014.
  • 15 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.